Roughly six years ago, former Israel chief technology officer Yonatan Adiri cofounded Healthy.io, a digital health care startup leveraging to bring professional-grade medical imaging to the homes of those with chronic kidney disease. Its 10-parameter digital testing kit – Dip.io – allows patients to collect and analyze urine samples with nothing more than a smartphone app, a dip-stick, and a color-coded slide.
It's been taken off wildfire. Following the heels of an $ 18 million series B raise in February, Healthy.io today announced that it's secured $ 60 million in a series C funding round led by Corner Ventures, with participation by Joy Capital and previous backers Ansonia Holdings, Aleph, and Samsung Next. CEO Adiri said the fresh capital, which brings Healthy.io's total raised to about $ 90 million, wants to accelerate Healthy.io's global expansion and product development.
Healthy.io, in turn, announced that it will receive its second 501
"The smartphone has the potential to be the great equalizer of healthcare, "Adiri said. "To unlock this potential, companies must adhere to the highest clinical standards. 100,000 patients in Europe and Israel, making it a reality for millions of Americans suffering from diabetes and hypertension, who are at risk for chronic kidney disease. Healthy.io Dip.io ” width=”800″ height=”531″ srcset=”https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=4288&strip=all 4288w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=300&strip=all 300w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=768&strip=all 768w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=800&resize=800%2C531&strip=all&strip=all 800w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=400&strip=all 400w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=780&strip=all 780w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=578&strip=all 578w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=930&strip=all 930w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=2000&strip=all 2000w, https://venturebeat.com/wp-content/uploads/2018/06/AppKit-2.jpg?w=3000&strip=all 3000w” sizes=”(max-width: 800px) 100vw, 800px” data-recalc-dims=”1″/>
Healthy.io's tests were designed with ease of use in mind with the companion app, after which the image is anonymous, tokenized, and beamed to the cloud for diagnostic tests. The medical-grade CE and ISO 13485 certified-for-sale kit performs urinalysis for a range of illnesses, infections, and pregnancy-related complications. Specifically, it tests for ketones, leukocytes, nitrites, glucose, protein, blood, specific gravity, bilirubin, urobilinogen, and pH markers that span pathologies from urinary tract infections to ketosis, kidney disease, pregnancy and bladder cancer.  For patients, the benefits are obvious: Taking pictures of urine samples is much less inconvenient than driving to a nearby hospital. As for clinicians, search at-home tests to find out more about hospital rooms and help hospital staff prioritizing urgent cases. "If you look at the exponential growth around the smartphone camera … it makes sense to leverage this growth to [use] it for diagnostic purposes," Adiri told VentureBeat in an earlier interview. "[Patients]"
Dip.io is highly effective, Adiri adds, both at encouraging patients to regularly and at the time of revealing signs of kidney dysfunction. In a triple-blind study of 500 subjects, 99% of people were able to complete a test. In an assessment of patients with hypertension conducted with Geisinger Health in conjunction with U.S. Pat. National Kidney Foundation, adherence rates were 71%. And, in the UK, where the Dip.io is available through the NHS Clinic in Yorkshire, in June, there was an undetected kidney disease.
"Today's health system does not make it easy for patients to get the care they need. Healthy.io is tackling this problem by meeting patients where they are, on their smartphones, and turning the smartphone into a clinical-grade medical device, "said Aleph General Partner Michael Eisenberg.
Dip.io is already being used by 100,000 patients via Healthy.io's strategic partnerships in Europe and Israel, Adiri says, and has been secured by FDA 510 (k) clearance in the US The firm's inked a global partnership with Siemens Healthineers, and it recently announced the launch of a cystitis testing service in London, Sheffield, and Cardiff. (Boots UK is a subsidiary of Walgreens parent company Walgreens Boots Alliance.)
Healthy.io is currently focused on international expansion, Adiri says, but its offerings will not be limited to urinalysis tests in the future. Computer vision algorithms correct and standardize image, and, as with Dip.io, send it to the cloud for analysis.
As part of this latest funding round, former executive vice president of Aetna Gary Loveman joined Healthy.io's board of directors. Loveman was an associate professor at the Harvard University Graduate School of Business Administration for nine years and he holds a Ph.D. in economics from M.I.T.